Objective:

To analyze the systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI) as independent risk factors for overall and specific cause mortality.

Approach:

• Study Overview: The study by Ke et al. examines the association of SII and SIRI with overall and specific cause mortality in a community cohort, highlighting their utility as biomarkers derived from complete blood count.
• Pathophysiological Context: The commentary discusses the differing biological implications of these indices in chronic versus acute inflammatory states, particularly in severe conditions like sepsis, where SII reflects hyperinflammation.

Key Findings:

• Both SII and SIRI are significantly associated with overall and specific cause mortality.
• The SII reflects hyperinflammation and hematologic consumption in acute settings, while indicating chronic inflammation in stable community cohorts.
• The SII is influenced by various systemic conditions and subclinical factors, which may lead to misleading prognostic classifications, particularly in emergency settings.

Interpretation:

The non-specific nature of the SII necessitates cautious interpretation, especially in the context of confounding factors such as chronic metabolic states and subclinical infections that can skew results.

Limitations:

• The SII is susceptible to confounding by chronic metabolic states and subclinical infections, necessitating further validation in diverse populations.
• Current evidence in Latin America is insufficient for broad clinical implementation without further validation.

Conclusion:

The SII may serve as a low-cost biomarker in emergency settings but requires rigorous validation before it can safely guide acute therapeutic decisions.

Sources:

• Frontiers in Medicine